OSE Immunotherapeutics Announces Publication of Peer-Reviewed Data on CLEC-1, its Novel Myeloid Immune Checkpoint in 'Science Advances' : vimarsana.com

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the publication of data in the peer-reviewed journal Science Advances on a first-in-classpreclinical

Related Keywords

Paris , France General , France , French , Sabrina Pengam , Debajyoti Sinha , Cedric Louvet , Isabelle Girault , Vanessa Gauttier , Maria Dolores Lopez , Javier Saenz , Nicolas Poirier , Virginie Thepenier , Emmanuelle Wilhelm , Thomas Guillot , Caroline Mary , Camille Ligeron , Emmanuel Merieau , Ariane Desselle , Elise Chiffoleau , Marion Drouin , Cynthia Fourgeux , Sylvie Berrebi David , Florence Portejoie , Nantes University Hospital , Translational Research In Transplantation , Linkedin , Nantes University At Hospital , Twitter , Boehringer Ingelheim , International Media , Veloxis Pharmaceuticals Inc , Regulatory News , Science Advances , Translational Research , Chief Executive Officer , C Type Lectin , Myeloid Derived Suppressor Cells , Translational Immunology , Nantes University , Non Small Cell Lung Cancer , Veloxis Pharmaceuticals , Universal Registration Document , Berrebi David Dible Eleanor Perkin , Immunotherapeutics , Nnounces , Ublication , Eer , Eviewed , Ata , Lec , Ovel , Yeloid , Mmune , Heckpoint , Cience , Dvances ,